Loading...
Rational study endpoints in anti-neoplastic agent regulatory approval trials in the gynecologic malignancies
A discussion of rational endpoints in clinical trials seeking regulatory approval for new anti-neoplastic agents involving the three major gynecologic malignancies, cancers of the ovary, cervix, and endometrial, is particularly interesting as (in the opinion of this commentator) the conclusion will...
Na minha lista:
| Udgivet i: | Womens Health (Lond) |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5373277/ https://ncbi.nlm.nih.gov/pubmed/27638892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1745505716655555 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|